Literature DB >> 9632535

Cytokines in juvenile rheumatoid arthritis (JRA).

H Mangge1, K Schauenstein.   

Abstract

Juvenile rheumatoid arthritis (JRA), unlike rheumatoid arthritis of adulthood (RA), is a heterogenous disease comprising at least five subtypes that differ in clinical course and prognosis, and require different therapeutical approaches. As compared to RA, the production of local and systemic cytokines in JRA have not yet been as extensively investigated. In this article we review the available literature on cytokine expression in serum and synovial fluid in all five different subtypes of JRA. Even though the data are still fragmentary, the evidence so far suggests that the determination of serum cytokines yields relevant information as to clinical subtype and inflammatory activity of the disease. Furthermore, the cytokine data suggest that the pathogenesis of JRA may even by more heterogenous than defined by the clinical subtypes. Finally, future directions of research in this area are proposed, and-based on the latest results-arguments for (anti)cytokine therapies in JRA are critically discussed. Copyright 1998 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632535     DOI: 10.1006/cyto.1997.0306

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  Clinical trials for the treatment of systemic onset juvenile rheumatoid arthritis-juvenile idiopathic arthritis.

Authors:  T J Lehman
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

Review 2.  The use of anakinra in juvenile arthritis.

Authors:  Andreas Reiff
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

3.  Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis.

Authors:  Harald Mangge; Bernd Heinzl; Hans-Michael Grubbauer; Yosuf El-Shabrawi; Konrad Schauenstein
Journal:  Rheumatol Int       Date:  2003-04-10       Impact factor: 2.631

4.  Low cortisol levels in active juvenile idiopathic arthritis.

Authors:  Yelda Bilginer; Rezan Topaloglu; Ayfer Alikasifoglu; Nazli Kara; Nesrin Besbas; Seza Ozen; Aysin Bakkaloglu
Journal:  Clin Rheumatol       Date:  2009-12-15       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.